Armenia – Two diseases. A chance to fight at once (ENG)

Just a short time ago, Hakobyan was suffering from two very serious infections, neither of which could be treated properly. The treatment he took for hepatitis C appears to have been successful … And he’s taking Bedaquiline — a new drug for drug-resistant TB — which has greatly increased his chances of survival.

MSF198962

To Report An Asset

If you think this image is in any way inappropriate, please report it, by including its URN/identifying code and a brief description of your concern in sending an email to [email protected]

Linked assets

Armenia – Two diseases. A chance to fight at once (without subtitles) (ENG)

No Subtitles (international)

Armenia – Two diseases. A chance to fight at once (DE)

Subt. German

Armenia – Two diseases. A chance to fight at once (INT)

Armenia – Two diseases. A chance to fight at once (FR)

Subt. French

Generic MSF

Add to lightbox

Add to cart

Unique Identifier Code / URN MSF198962

Date taken / Date Recorded 25/04/2017 12:00 AM

Country Armenia

Commissioning section MSF-FRANCE

Photographer / videographer / producer Simon Rolin

Usage Rights (MSF) Advertising Campaign, External Media, MSF Fundraising, MSF Publications, Social Media

Formal Consent Copy available no

Editor's rating ★★★★★ (C)

Video format h264 (Constrained Baseline) (avc1 / 0x31637661)

Duration 1m15s

Maximum Size 1920px × 1080px 127.39 MB

Additional Information / Shotlist ARMENIA
Significant headway has been made in treating hepatitis C with the advent of highly effective and less toxic Direct Acting Antivirals.
DAAs also enable patients co-infected with drug-resistant tuberculosis to continue their all-essential anti-TB treatment.
Hakobyan has a drug-resistant form of tuberculosis. He’s been on treatment for 16 months.

HAKOBYAN (in Armenian)
When you’re taking treatment for TB, they monitor your heart, liver and other parts of your body. They found out I had hepatitis C when they did some tests.

Hakobyan was able to benefit from the new generation of hepatitis C drugs — Direct Acting Antivirals. Three months on, the virus was no longer detected in his blood — he still has to wait for a second test to confirm he is cured.

MARIE-JEAN PARE, country representative, MSF (in French)
The programme is still in the early stages, but so far, all patients who’ve been put on these new treatments have had very positive results and only a few side effects.

Just a short time ago, Hakobyan was suffering from two very serious infections, neither of which could be treated properly. The treatment he took for hepatitis C appears to have been successful … And he’s taking Bedaquiline — a new drug for drug-resistant TB — which has greatly increased his chances of survival.

Keywords

Access to Medicines

Hepatitis C

Multidrug-Resistant Tuberculosis